Condensed Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended		6 Months Ended		248 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Income Statement [Abstract]
Revenue	$ 18,432	$ 250,000	$ 36,864	$ 500,000	$ 1,467,584
Operating expenses:
General and administrative	370,924	418,676	810,604	865,039	71,293,097
Research and development		20,545		41,239	116,092,348
Sub-license and Option Fees					26,536
Purchased in-process research and development					12,146,544
Operating expenses before accrual reversal	370,924	439,221	810,604	906,278	199,558,525
Accrual reversal			(405,026)		(966,221)
Total operating expenses	370,924	439,221	405,578	906,278	198,592,304
Loss from operations	(352,492)	(189,221)	(368,714)	(406,278)	(197,124,720)
Interest expense	(111,243)	(105,716)	(222,110)	(209,113)	(15,145,771)
Realized loss on sale of marketable securities	(56,317)		(227,083)		(227,083)
Investment income		29		277	7,705,345
Other income (expense), net				905	(1,473,159)
Gain on early extinguishment of debt					6,277,100
Forgiveness of debt					476,837
Net loss	(520,052)	(294,908)	(817,907)	(614,209)	(199,511,451)
Preferred stock beneficial conversion feature					(8,062,712)
Accrual of preferred stock dividends and modification of warrants held by preferred stock stockholders					(1,229,589)
Net loss attributable to common stockholders	(520,052)	(294,908)	(817,907)	(614,209)	(208,803,752)
Other comprehensive income
Unrealized holding gain (loss) arising during the year	(6,306)		49,186		(260,018)
Less: reclassification adjustments for loss on Sale included in net loss	56,317	(12,938)	227,083	(7,057)	227,083
Net unrealized gain (loss) on marketable securities	50,011	(12,938)	276,269	(7,057)	(32,935)
Comprehensive loss	$ (470,041)	$ (307,846)	$ (541,638)	$ (621,266)	$ (208,836,687)
Basic and diluted net loss attributable to common stockholders per share	$ (0.02)	$ (0.01)	$ (0.03)	$ (0.02)
Weighted average common shares outstanding	30,635,720	30,635,720	30,635,720	30,635,720